Dataset Information

Proteasome-dependent truncation of the negative heterochromatin regulator Epe1 mediates antifungal resistance.

ABSTRACT: Epe1 histone demethylase restricts H3K9-methylation-dependent heterochromatin, preventing it from spreading over, and silencing, gene-containing regions in fission yeast. External stress induces an adaptive response allowing heterochromatin island formation that confers resistance on surviving wild-type lineages. Here we investigate the mechanism by which Epe1 is regulated in response to stress. Exposure to caffeine or antifungals results in Epe1 ubiquitylation and proteasome-dependent removal of the N-terminal 150 residues from Epe1, generating truncated tEpe1 which accumulates in the cytoplasm. Constitutive tEpe1 expression increases H3K9 methylation over several chromosomal regions, reducing expression of underlying genes and enhancing resistance. Reciprocally, constitutive non-cleavable Epe1 expression decreases resistance. tEpe1-mediated resistance requires a functional JmjC demethylase domain. Moreover, caffeine-induced Epe1-to-tEpe1 cleavage is dependent on an intact cell-integrity MAP kinase stress signalling pathway, mutations in which alter resistance. Thus, environmental changes provoke a mechanism that curtails the function of this key epigenetic modifier, allowing heterochromatin to reprogram gene expression, thereby bestowing resistance to some cells within a population. H3K9me-heterochromatin components are conserved in human and crop plant fungal pathogens for which a limited number of antifungals exist. Our findings reveal how transient heterochromatin-dependent antifungal resistant epimutations develop and thus inform on how they might be countered.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Schizosaccharomyces Pombe 927

TISSUE(S): Cell Suspension Culture, Cell Culture

SUBMITTER: Imtiyaz Yaseen

LAB HEAD: Robin Allshire

PROVIDER: PXD030205 | Pride | 2022-10-13

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	Yaseen_2021_ControlUntagged2_Rep1.raw	Raw
	Yaseen_2021_ControlUntagged2_Rep2.raw	Raw
	Yaseen_2021_ControlUntagged2_Rep3.raw	Raw
	Yaseen_2021_ControlUntagged_Rep1.raw	Raw
	Yaseen_2021_ControlUntagged_Rep2.raw	Raw

Items per page:

1 - 5 of 47

Publications

Proteasome-dependent truncation of the negative heterochromatin regulator Epe1 mediates antifungal resistance.

Yaseen Imtiyaz I White Sharon A SA Torres-Garcia Sito S Spanos Christos C Lafos Marcel M Gaberdiel Elisabeth E Yeboah Rebecca R El Karoui Meriem M Rappsilber Juri J Pidoux Alison L AL Allshire Robin C RC

Nature structural & molecular biology 20220725 8

Epe1 histone demethylase restricts H3K9-methylation-dependent heterochromatin, preventing it from spreading over, and silencing, gene-containing regions in fission yeast. External stress induces an adaptive response allowing heterochromatin island formation that confers resistance on surviving wild-type lineages. Here we investigate the mechanism by which Epe1 is regulated in response to stress. Exposure to caffeine or antifungals results in Epe1 ubiquitylation and proteasome-dependent removal o ...[more]

PMID: 35879419

Similar Datasets

Project description:Fungal infections are a serious health problem in clinics especially in the immune-compromised patient. Disease ranges from widespread superficial infections like vulvovaginal infections to life-threatening systemic candidiasis. Especially for systemic mycoses only a limited arsenal of antifungals is available. The most commonly used classes of antifungal compounds used include azoles, polyenes and echinocandines. Due to emerging resistance to standard therapy and significant side effects and high costs for several antifungals.,there is a medical need for new antifungals in the clinic and general practice. In order to expand the arsenal of compounds with antifungal activities we previously screened a compound library, using a new type of activity-selectivity (AS) assay analysing both the antifungal activity and the compatibility with human cells at the same time. One compound, ((S)-2-(1-aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole (EMC120B12)), showed high antifungal activity against several species of pathogenic yeasts including C. glabrata and C. krusei, species which are highly refractory to antifungals, especially to the commonly used azoles. Here we could show by transcriptional profiling and sterol analysis that the target of this new antifungal compound is the ergosterol pathway. The effects of EMC120B12 on sterol biosynthesis mimic those of fluconazole, strongly indicating that EMC120B12 also targets ERG11 like the azols. But not only the marker sterol 14 methylergosta 8,24(28) dien 3β,6α diol accumulated in C. krusei under EMC120B12 treatment, but also hitherto unknown related sterols. The novel sterols have a 3β,6α diol structure. Furthermore, this is the first time that a benzimidazole structure has been shown to result in a block of the sterol pathway by accumulating marker sterols connected to ERG11 inactivation. In total, three biological replicates were performed. All experiments were performed as dye swaps. Thus, in total 18 arrays have been hybridzed. Hybridization experiments included an untreated reference sample and a sample of cells treated with either ((1S)-1-[1-(3-chlorobenzyl)-1H-benzimidazol-2-yl]-2-methylpropyl-amine) (EMC120B12), Fluconazole or Nocodazole. The array included one technical replicate of each probe.

Dataset Information

Proteasome-dependent truncation of the negative heterochromatin regulator Epe1 mediates antifungal resistance.

Dataset's files

Publications

Proteasome-dependent truncation of the negative heterochromatin regulator Epe1 mediates antifungal resistance.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets